Mostrar el registro sencillo del ítem
dc.contributor.author | Jódar Gimeno, José Esteban | |
dc.contributor.author | Doshi, Ankur | |
dc.contributor.author | Gouet, D. | |
dc.contributor.author | Oviedo, A. | |
dc.contributor.author | Rodbard, H.W. | |
dc.contributor.author | Tentolouris, Nikolaos | |
dc.contributor.author | Busk, A.K. | |
dc.contributor.author | Basse, A. | |
dc.contributor.author | Billings, Liana K. | |
dc.date.accessioned | 2018-04-16T08:27:32Z | |
dc.date.available | 2018-04-16T08:27:32Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Jódar Gimeno, E., Doshi, A., Gouet, D., Oviedo, A., Rodbard, H.W., Tentolouris, N., Busk, A.K., Basse, A., & Billings, L.K. (2017). Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolustherapy in patients with type 2 diabetes: DUAL VII trial. Trabajo presentado en la 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). | spa |
dc.identifier.uri | http://hdl.handle.net/11268/7224 | |
dc.description.sponsorship | Novo Nordisk A/S | spa |
dc.language.iso | eng | spa |
dc.title | Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial | spa |
dc.type | conferenceObject | spa |
dc.description.impact | No data (2017) | spa |
dc.rights.accessRights | closedAccess | spa |
dc.subject.uem | Diabetes tipo 2 | spa |
dc.subject.uem | Insulina | spa |
dc.subject.unesco | Sistema endocrino | spa |
dc.subject.unesco | Tratamiento médico | spa |
dc.description.filiation | UEM | spa |
dc.peerreviewed | Si | spa |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |